6 unknown, 1 completed, 1 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 6, Completed 1, Terminated 1 |
Follow Drug Resistant Epilepsy: new trials by email Literature Review of Drug Resistant Epilepsy trials Research Report on Drug Resistant Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children Valproic acid, Carbamazepin, Phenytoin - Drug Resistant Epilepsy | Phase 4 | Unknown | Dr Cipto Mangunkusumo General Hospital | 100 | 2023-03-01 | 2023-01-26 |
| Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes Fenfluramine - Refractory Epilepsy, SYNGAP1 Encephalopathy | Phase 4 | Completed | Hospital Ruber Internacional | 20 | 2022-10-20 | 2026-09-29 |
| Role of the Gut Microbiota in Pediatric Epilepsy Prebiotic, Placebo - Drug Resistant Epilepsy | Phase 4 | Unknown | British Columbia Children's Hospital | 45 | 2021-06-01 | 2022-03-09 |
| Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma | Phase 4 | Terminated | Mayo Clinic | 4 | 2020-12-04 | 2023-06-22 |
| Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children RiTUXimab Injection [Rituxan] - Refractory Epilepsy | Phase 4 | Unknown | Assiut University | 140 | 2020-10-01 | 2020-09-09 |
| Comparison of Efficacy of LGIT and MAD Among Children With Drug Resistant Epilepsy Low glycemic Index Therapy (LGIT), Modified Atkins Diet (MAD) - Drug Resistant Epilepsy, Ketogenic Dieting | Phase 4 | Unknown | All India Institute of Medical Sciences | 110 | 2018-12-26 | 2019-09-10 |
| Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy clobazam (Onfi), Initial conversion and titration, Conversion schedule - Week 1 - Refractory Epilepsy | Phase 4 | Unknown | St. Joseph's Hospital and Medical Center, Phoenix | 21 | 2013-02-01 | 2017-03-03 |
| The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy Reduction of anti-epileptic medications, No drug change - Intractable Epilepsy | Phase 4 | Unknown | Institute of Child Health | 64 | 2008-09-01 | 2008-03-31 |
Epilepsy (4) · Brain Diseases (1) · Chromosome 15q, tetrasomy (1) · Epileptic Encephalopathy, Early Infantile, 4 (1) · Genetic Diseases, Inborn (1) · Glioma (1) · Nervous System Diseases (1)
Central Nervous System Diseases (8) · Brain Diseases (7) · Nervous System Diseases (7) · Epilepsy (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
Clobazam (2) · Adrenal Cortex Hormones (1) · Anticonvulsants (1) · Carbamazepine (1) · Diet, Ketogenic (1) · Fenfluramine (1) · Lamotrigine (1) · Oxcarbazepine (1) · Phenytoin (1) · Prebiotics (1) · Rituximab (1) · Trace Elements (1) · Valproic Acid (1) · perampanel (1)
All India Institute of Medical Sciences (1) · Assiut University (1) · British Columbia Children's Hospital (1) · Dr Cipto Mangunkusumo General Hospital (1) · Hospital Ruber Internacional (1) · Institute of Child Health (1) · Mayo Clinic (1) · St. Joseph's Hospital and Medical Center, Phoenix (1)
United States (2) · Canada (1) · India (1) · Indonesia (1) · Spain (1) · United Kingdom (1)
Antonio Gil-Nagel, MD, PHD (1) · Sheffali Gulati, MD (1) · Steve Chung, MD (1) · William Tatum (1)